FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services Haloperidol Decanoate Injection Recall

Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufacture…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Apr 30, 2025
Recall ID
D-0367-2025
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Haloperidol Decanoate Injection starting Apr 2, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0367-2025 on Apr 30, 2025. Reason: Lack of assurance of sterility. Bacterial contamination detected in some media fill units. Status: Ongoing.

Why it was recalled

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Product description

Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.

Lot numbers, UPCs & expiration codes

A240467B, EXP 07/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0367-2025
Classification
Class II
Status
Ongoing
Recall initiated
Apr 2, 2025
FDA report date
Apr 30, 2025
Quantity
2,110 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0367-2025, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
96636
Address
2550 John Glenn Ave Ste A
Code information
A240467B, EXP 07/31/2026
Postal code
43217-1188
Report date
Apr 30, 2025
Product type
Drugs
Recall number
D-0367-2025
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
2,110 vials
Reason for recall
Lack of assurance of sterility. Bacterial contamination detected in some media fill units
Voluntary / mandated
Voluntary: Firm initiated
Product description
Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 2, 2025
Initial firm notification
Letter
Center classification date
Apr 18, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0367-2025, published Apr 30, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls